Inventor · disambiguated record
Alistair James Henry
Also filed as: HENRY ALISTAIR J · HENRY ALISTAIR JAMES
8 granted patents·3 pending applications·268 citations·filing 2006–2024
86Inventor score
Top patents by PatentIndex Score
11 records- 0197US7872106B2Sclerostin-binding antibodiesAMGEN INC·Filed 2008·Granted Jan 18, 2011·86 cites·25 claims
- 0296US7592429B2Sclerostin-binding antibodyUCB SA·Filed 2006·Granted Sep 22, 2009·166 cites·5 claims
- 0387US8003108B2Sclerostin epitopesAMGEN INC·Filed 2006·Granted Aug 23, 2011·11 cites·15 claims
- 0478US8679494B2Antibodies specific to IL-17A and IL-17FCESKA THOMAS ALLEN·Filed 2009·Granted Mar 25, 2014·4 cites·6 claims
- 0576US2025011473A1ANTI-IgE ANTIBODIESUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 0671US12054559B2Anti-IgE antibodiesUCB Biopharma SRL·Filed 2021·Granted Aug 6, 2024·0 cites·12 claims
- 0767US12018021B2Thiophene derivatives for the treatment of disorders caused by IgEUCB Biopharma SRL·Filed 2019·Granted Jun 25, 2024·1 cites·15 claims
- 0860US2018037646A1Epitopes of il-17a and il-17f and antibodies specific theretoUCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
- 0957US11214627B2Anti-IgE antibodiesUCB Biopharma SRL·Filed 2017·Granted Jan 4, 2022·0 cites·15 claims
- 1051US2013203968A1Antibody-based diagnostics and therapeuticsAMGEN INC·Filed 2013·Application pending·0 cites
- 1148US10048253B2Method for identifying compounds of therapeutic interestUCB PHARMA SA·Filed 2013·Granted Aug 14, 2018·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →